WA Seattle의 버킷 림프종 임상 시험
버킷 림프종 관련 연구 14개가 Seattle 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
피험자 모집 중1상
- Seattle Children's Hospital, Seattle
Asciminib and Inotuzumab Ozogamicin for Relapsed or Refractory Philadelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia (R/R Ph+ B-ALL)
피험자 모집 중1상
- University of Washington Fred Hutchinson Comprehensive Cancer Center, Seattle
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
피험자 모집 중2상
- Seattle Children's Hospital, Seattle
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
피험자 모집 중3상
- Swedish Medical Center-First Hill, Seattle
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
피험자 모집 중2상
- Seattle Children's Hospital, Seattle
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
피험자 모집 중2상
- Seattle Children's Hospital, Seattle
Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma
피험자 모집 중2상
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
피험자 모집 중3상
- Fred Hutchinson Cancer Research Center, Seattle
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
피험자 모집 중3상
- Seattle Children's Hospital, Seattle
Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia
피험자 모집 중
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
피험자 모집 중2상건강한 지원자 환영
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Study of SGR-1505 in Mature B-Cell Neoplasms
피험자 모집 중1상
- Fred Hutchinson Cancer Center, Seattle
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
피험자 모집 중1상
- Fred Hutchinson Cancer Research Center, Seattle
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
피험자 모집 중1상
- Fred Hutchinson Cancer Center, Seattle
다른 도시의 버킷 림프종 시험
- Houston, TX연구 20개
- Milwaukee, WI연구 16개
- Chicago, IL연구 15개
- Philadelphia, PA연구 15개
- Atlanta, GA연구 13개
- New York City, NY연구 13개
- Cincinnati, OH연구 13개
- Los Angeles, CA연구 10개
- Baldwin Park, CA연구 10개
- Aurora, CO연구 10개
- Durham, NC연구 10개
- Kansas City, MO연구 10개
Seattle의 다른 연구
- 비소세포폐암연구 55개
- 암 (전체)연구 48개
- 전립선암연구 45개
- 급성 골수성 백혈병연구 40개
- 전이성 암연구 39개
- 유방암연구 37개
- 대장직장암연구 35개
- 폐암연구 34개
- 난소암연구 29개
- 췌장암연구 22개
- 다발성 골수종연구 22개
- 급성 림프모구성 백혈병연구 22개
ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.